Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$723K Sell
27,252
-143
-0.5% -$3.88K 0.08% 99
2024
Q3
$793K Sell
27,395
-519
-2% -$15.1K 0.09% 100
2024
Q2
$781K Sell
27,914
-2,655
-9% -$73.1K 0.09% 103
2024
Q1
$848K Sell
30,569
-534
-2% -$14.8K 0.1% 104
2023
Q4
$895K Buy
+31,103
New +$940K 0.11% 92

Other funds holding PFE

HTLF Bank's PFE Position: Q4 2024 in Review

HTLF Bank reduced its Pfizer (PFE) stake by 0.52% in Q4 2024, selling an estimated $3.88K and leaving 27,252 shares worth $723K. The position accounts for 0.08% of the portfolio, ranked #99.

HTLF Bank first reported a position in PFE in Q4 2023 and has held it in 5 quarters since. The position peaked at $895K in Q4 2023. 2,995 funds tracked by Wall St. Rank hold PFE as of Q4 2024.

  • HTLF Bank held 27,252 shares of Pfizer worth $723K as of Q4 2024.
  • HTLF Bank sold 143 Pfizer shares in Q4 2024, an estimated $3.88K.
  • Pfizer made up 0.08% of HTLF Bank's portfolio in Q4 2024, its #99 holding.
  • HTLF Bank first reported a position in Pfizer in Q4 2023 and has held it in 5 quarters since.
  • HTLF Bank's Pfizer position peaked at $895K in Q4 2023.
  • 2,995 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.

Based on HTLF Bank's 13F filing for Q4 2024, filed 28 Jan 2025.